[In the News] Executive Director Marjorie A. Speers, Ph.D., Speaks Out on Need for Diversity in COVID-19 Vaccine Trials

Clinical Research Pathways Executive Director Marjorie A. Speers, Ph.D., an epidemiologist and longstanding advocate for diversity in clinical research, has been featured in a number of news stories on the need to include Black and Latino participants in COVID-19 vaccine trials. To do otherwise, will “end up creating a greater health disparity,” she says.

2020-08-30T10:14:21-04:00August 10, 2020|News|

[News] FDA Streamlines Process for Single Patient Expanded Access During Pandemic

The Food and Drug Administration (FDA) has issued new Expanded Access guidance to help physicians understand and use the Expanded Access process to treat patients with investigational drugs and biologics during the COVID-19 public health emergency. 

The new guidance allows physicians applying for single patient expanded access to request a waiver of the […]

2020-06-08T12:37:22-04:00June 8, 2020|News|

[News Release] Clinical Research Pathways Partners with WellStar Health System to Increase Diversity in Clinical Trials

Grant to promote minority participation in cancer research

ATLANTA, December 12, 2019—Clinical Research Pathways is partnering with WellStar Health System to increase diversity in oncology research to help ensure that new cancer medicines are effective for patients of all races and ethnicities.

The two organizations—a nonprofit focused on creating pathways to new medicines and treatments, and one […]

2019-12-12T09:21:29-05:00December 12, 2019|News|

Clinical Research Pathways Submits Comments on FDA Draft Guidance on Diversity in Clinical Trials

Marjorie A. Speers, Ph.D., executive director of Clinical Research Pathways, recently submitted comments on FDA draft guidance on enhancing the diversity of clinical trial populations. The comments reflect Clinical Research Pathways’ commitment to enrolling more minority patients in clinical research. If the demographic mix of clinical trial participants mirrors that of […]

2019-09-09T19:29:49-04:00September 9, 2019|News|

[News Release] Clinical Research Pathways Taps Emory Physician for Board of Directors

Dr. Derek West chosen for clinical research and mentoring experience

ATLANTA, May 30, 2019Clinical Research Pathways has appointed Dr. Derek West, cancer researcher and interventional radiologist, to its board of directors.

He joins six other directors, all chosen for their commitment to Clinical Research Pathways’ goals of increasing diversity in clinical […]

2019-05-29T14:43:00-04:00May 29, 2019|News|

[News Release] Morehouse School of Medicine Awarded $200,000 to Train Minority Physicians for Recruiting Minorities in Clinical Trials

Funded by Clinical Research Pathways, the New Program Intends to Fill a Gap in the Percentage of Minorities Who Participate in Clinical Trials

ATLANTA, September 20, 2018 — Morehouse School of Medicine (MSM) will launch a program specifically designed to increase the number of African American, Latino and other minority patients in clinical trials, in an […]

2019-04-16T10:03:35-04:00September 20, 2018|News|

Clinical Research Pathways Names Two New Directors

ATLANTA, Ga., June 5, 2018 — Clinical Research Pathways has appointed two new members to its board of directors: Anne B. Cropp of Early Access Care and Andrew McFadyen of The Isaac Foundation and Equal Access for Rare Disorders.

The former WCG Foundation, Clinical Research Pathways is a public charity that works to improve health and well-being […]

2018-07-02T16:11:41-04:00June 5, 2018|News|

Republicans Get Ready to Vote on “Right-to-Try” Bill Again

Published March 19, 2018 by The American Journal of Managed Care

The right-to-try bill, which suffered a surprise 259-140 defeat in the House of Representatives last week, is scheduled for another vote this week, perhaps as early as Wednesday.

On Monday, the House Committee on Rules was scheduled to meet late in the day to change the […]

2018-07-02T15:04:00-04:00March 19, 2018|News|
Load More Posts
Go to Top